Select Your Region

We noticed you visit this page from United States. Please select your preferred region to continue

Go to United States (English)

skip to content

What are you looking for?

Instruments
Capillary Electrophoresis
MINICAP FLEX-PIERCING
CAPILLARYS 3 OCTA
CAPILLARYS 3 TERA
CAPILLARYS 3 TERA MC
CAPILLARYS 3 DBS
Gel Electrophoresis
HYDRASYS 2 SCAN FOCUSING
Indirect Immunofluorescence Assays (IFA)
dIFine® automated microscope
dIFine® M1 manual microscope
dIFine® P15 processor
dIFine® P30 processor
Open System ELISA
SMC Technology
Alegria 2
Random access CLIA based
Alegria Flash
dIFine® family: Experience the Difference
PHORESIS
Comprehensive data analysis and interpretation software for Sebia assays on Electrophoresis instruments.
PHORESIS
Tests
Pathologies
Oncology
Multiple Myeloma
Metabolic Diseases
Diabetes
Chronic Alcohol Abuse
Bone Metabolism
Genetic Diseases
Hemoglobin Disorders
Alpha-1 Antitrypsin Deficiency
von Willebrand Disease
Autoimmune Diseases
Central Nervous System Inflammatory Disease
Rheumatoid Arthritis
Connective Tissue Diseases
Antiphospholipid Syndrome
Vasculitis
Autoimmune Liver and Gastric Diseases
Inflammatory Bowel Diseases
Celiac Disease
Autoimmune Thyroid Diseases
Autoimmune Diabetes
Organ-Specific Autoimmune Diseases
Infectious diseases
Anti-MCV – Fill the gap in rheumatoid arthritis diagnosis
Knowledge & Science
Browse Sebia's scientific and educational resources, including webinars, publications, posters, white papers, brochures, catalogues, and customer testimonials.
Learn more
Services
Sebia Lean Service
Sebia Service
Sebia Academy
Knowledge & Science
About Sebia
Company Overview
Worldwide Presence
Research & Innovation
Quality & Compliance
Corporate and Social Responsibility
Join us

What are you looking for?

News & Stories
Careers
Contact
My Sebia

Country Selector

Based on your location

United States
English

Corporate website

English French German Italian Spanish

Europe

Austria
German
Belgium
English French
Czechia
English
France
French
Germany
German
Italy
Italian
Luxembourg
English French
Portugal
Portuguese
Slovakia
English
Spain
Spanish
Switzerland
English French German Italian
Netherlands
English
United Kingdom
English

North America

Canada
English French
United States
English

Latin America

Brazil
Portuguese

Asia-Pacific

China
Chinese
India
English
Japan
Japanese

Knowledge & Science

Results

Filter facets

Knowledge & Science

Brochure & Catalog (4)
Publication & Poster (30)
White Paper (3)
Webinar (33)
Customer Testimonial (5)

Pathologies

Multiple Myeloma (21)
Diabetes (10)
Chronic Alcohol Abuse (10)
Hemoglobin Disorders (14)
Alpha-1 Antitrypsin Deficiency (5)

Instruments

MINICAP FLEX-PIERCING (20)
CAPILLARYS 3 OCTA (27)
CAPILLARYS 3 TERA (27)
CAPILLARYS 3 TERA MC (26)
CAPILLARYS 3 DBS (6)

Technologies

Capillary Electrophoresis (35)
Gel Electrophoresis (19)
IFA (3)
SMC Technology (14)
ELISA (22)

Tests

Serum Protein by Capillary Electrophoresis (9)
Urine Protein by Capillary Electrophoresis (5)
Serum and Urine Immunotyping (7)
Serum Protein by Agarose Gel Electrophoresis (4)
Urine Protein by Agarose Gel Electrophoresis (2)

Carbohydrate-deficient transferring testing: a truly traceable and specific biomarker for chronic alcohol misuse
Improving diagnosis of von Willebrand disease
Biomarkers for harmful alcohol use should be reliable, standardised, and traceable
Interview with M. Jean Deenmamode, CDT IFCC Working Group Chair
Evaluation of a semi-automated von Willebrand factor multimer assay
Evaluation of Sebia’s isoelectrofocusing kit for A1AT

67-72 of 75 results

9
10
11
12
13

Subscribe to our Newsletter

Don’t miss any insights, subscribe now to receive our communications

Connect with us

Our mission is to provide healthcare professionals with powerful tools that translate complex biological signals into clear, actionable insights.

Solutions

Instruments
Tests
Software

Services

Sebia Lean Service
Sebia Service
Sebia Academy

Sebia

Who we are
Contact us
Join us
Corporate and Social Responsibility

Copyright © Sebia 2026

Legal notice
Privacy policy
Accessibility statement